B and T cell responses to the 3rd and 4th dose of the BNT162b2 vaccine in dialysis patients

B and T cell responses to the 3rd and 4th dose of the BNT162b2 vaccine in dialysis patients

ABSTRACTPatients on dialysis (PoD) are at high risk of severe morbidity and mortality from COVID-19. Characterizing long-term vaccine immune responses in these patients will help optimize vaccine schedule for PoD. This study aimed to determine whether long-term humoral and B and T cell-responses pos...

Full description

Bibliographic Details
Main Authors: Younes Bathish, Neta Tuvia, Elizabeth Eshel, Tali Tal Lange, Christiane Sigrid Eberhardt, Michael Edelstein, Kamal Abu-Jabal
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
B cells
COVID-19
dialysis
SARS-CoV-2
T cells
vaccine
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2023.2292376

Internet

https://www.tandfonline.com/doi/10.1080/21645515.2023.2292376

Similar Items